Investigational Site Number 840329 — South Bend, Indiana

Investigational Site Number 840329 is a clinical research site located in South Bend, Indiana, United States 46601.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number 840329 has participated in 1 clinical trials.

Therapeutic areas: Squamous Cell Lung Cancer.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number 840329?

Investigational Site Number 840329 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number 840329 conducted?

Investigational Site Number 840329 has 1 clinical trials on record. Their work covers Squamous Cell Lung Cancer.

Is Investigational Site Number 840329 accredited by Crixeo Health?

Investigational Site Number 840329 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number 840329?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.